Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy (vol 10, e0144359, 2015)

被引：1
|
作者：
Bonsang-Kitzis, Helene
Chaltier, Leonor
Belin, Lisa
Savignoni, Alexia
Rouzier, Roman
Hamy, Anne-Sophie [1 ]
Sablin, Marie-Paule [2 ]
Lerebours, Florence
Bidard, Francois-Clement
Cottu, Paul
Sastre-Garau, Xavier
Lae, Marick
Pierga, Jean-Yves
Reyal, Fabien
机构：
[1] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment Lab, Paris, France
[2] INSERM, Immun & Canc UMR932, Paris, France
来源：
PLOS ONE | 2016年 / 11卷 / 07期
关键词：
D O I：
10.1371/journal.pone.0159123
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of body mass index (BMI) on the predictive and prognostic value of stromal tumor-infiltrating lymphocytes (sTIL) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NACT)
    Desmedt, Christine
    Richard, Francois
    Jongen, Lynn
    Hamy-Petit, Anne-Sophie
    Wildiers, Hans
    Ardui, Jan
    Punie, Kevin
    Smeets, Ann
    Berteloot, Patrick
    Vergote, Ignace
    Lae, Maricl
    Decroze, Diane
    Meseure, Didier
    Reyal, Fabien
    Biganzoli, Elia
    Neven, Patrick
    Floris, Giuseppe
    CANCER RESEARCH, 2020, 80 (04)
  • [42] High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer
    Klauber-DeMore, N
    Kuzmiak, C
    Rager, EL
    Ogunrinde, OB
    Ollila, DW
    Calvo, BF
    Kim, HJ
    Meyer, A
    Dees, C
    Graham, M
    Collichio, FA
    Sartor, CI
    Metzger, R
    Carey, LA
    AMERICAN JOURNAL OF SURGERY, 2004, 188 (04): : 386 - 389
  • [43] Analysis of the Clinical Molecular Characteristics and Neoadjuvant Chemotherapy Response in Patients with Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and Axillary Lymph Node Metastasis
    Ma, Jin-Ping
    Zhang, Yong
    Fang, Sheng
    Zhang, Jian
    Zhang, Jia-Hong
    Wang, Teng
    Ma, Yuan
    Wang, Hai-Bo
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (06):
  • [44] PostTreatment High Ki67 Expression Level (>10%) Is Significantly Associated with Distant Metastasis in Triple-Negative Breast Carcinomas Treated with Neoadjuvant Chemotherapy Followed by Surgery
    Duan, L.
    Yan, J.
    Sarode, V.
    Rao, R.
    Leitch, A. M.
    Euhus, D.
    Cao, D.
    Xie, X-J
    Peng, Y.
    MODERN PATHOLOGY, 2011, 24 : 37A - 37A
  • [45] PostTreatment High Ki67 Expression Level (>10%) Is Significantly Associated with Distant Metastasis in Triple-Negative Breast Carcinomas Treated with Neoadjuvant Chemotherapy Followed by Surgery
    Duan, L.
    Yan, J.
    Sarode, V.
    Rao, R.
    Leitch, A. M.
    Euhus, D.
    Cao, D.
    Xie, X-J
    Peng, Y.
    LABORATORY INVESTIGATION, 2011, 91 : 37A - 37A
  • [46] Radiomics multi-parametric MRI of before and after neoadjuvant chemotherapy associated with axillary lymph node metastasis and prognostic in patients with breast cancer: A multicenter RBC-002 study
    Yao, Herui
    Li, ChenChen
    Yu, Yunfang
    Xie, Chuanmiao
    Ouyang, Jie
    Tan, Yujie
    Lu, Nian
    Wang, Ying
    Zhao, Jianli
    Chen, Kai
    Ma, Jiafan
    CANCER RESEARCH, 2020, 80 (04)
  • [47] Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
    Dong, Xue
    Liu, Congfang
    Yuan, Jiaqi
    Wang, Shouman
    Ding, Nianhua
    Li, Yong
    Wu, Yuhui
    Xiao, Zhi
    BREAST CARE, 2021, 16 (04) : 328 - 334
  • [48] CD10 expression as a potential predictor of pathological complete response in ER-negative and triple-negative breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Dimitrov, George
    Shousha, Sami
    Troianova, Petranka
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2024, 135
  • [49] Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
    Gwark, Sungchan
    Noh, Woo Chul
    Ahn, Sei Hyun
    Lee, Eun Sook
    Jung, Yongsik
    Kim, Lee Su
    Han, Wonshik
    Nam, Seok Jin
    Gong, Gyungyub
    Kim, Seon-Ok
    Kim, Hee Jeong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] The Utility of MRI in Predicting Response of Lymph Nodes in HER2-positive and Triple-negative Breast Cancer to Combination Neoadjuvant Immunotherapy and Chemotherapy (NAICT) and Its Implications on Axillary Surgical Management
    Rajarajan, Noeline
    Weinfurtner, Robert
    Kiluk, John
    Lee, Catherine
    Czerniecki, Brian
    Khakpour, Nazanin
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S378 - S379
12345